Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II Study

NCT00462423 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Malignant Melanoma

Interventions

DRUG: Avastin
DRUG: Abraxane

Sponsor

Lynn E. Spitler, MD

Collaborators

[object Object]
[object Object]